SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IVPH -- INNOVIVE Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: bookert11 who wrote (68)2/19/2008 4:51:44 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 117
 
Nobody can.

:-(

Do you know the history of Rosenwald? Do you know the history of Genta? Rosenwald guided Genta into a low-ball financing ('98), off of which it did 20X.

finance.yahoo.com

That long plateau from 2000-2004? While I wasn't a believer, Genta's science was taken seriously.... the company was taking a legitimate shot in the clinic.

Seems to me that the Q. is....... Is Rosenwald pulling a Genta, or were all of the IVPH molecules crap to begin with? I don't have insight, not a frigging clue. But I do enjoy 20X rides, so please share if you get some.

:-)



To: bookert11 who wrote (68)2/19/2008 10:08:40 PM
From: bookert11  Respond to of 117
 
yeah...i knew that too.Had sum1 inform me abt this a few months ago. good to see people on here are still following this stock though. For awhile I thought i was the only one still here. I say this company will pull it off if they can get through this year, But this isnt based off any fact only a hunch.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News